Scientific Leadership • Research Strategy • Scientific Operations • AI × Biology

Navneet Jawanda, PhD, PMP

From doing science → enabling science → orchestrating science → reimagining science with AI.

Scientific leader with over 15 years of education, training and experience spanning molecular biology, translational research, drug discovery, scientific operations, and program management, bridging deep biological expertise with AI and computational approaches to advance next-generation biomedical research and therapeutic innovation.

Career Story

I began my career at the bench, building a deep foundation in molecular biology, protein sciences, virology, cell biology, structural biology, bioassay development, and translational research. That scientific foundation led naturally into hands-on therapeutic and preclinical drug-discovery work, including anti-HIV interventions spanning small molecules and novel bi-functional antibody-recruiting HIV-envelope attachment inhibitors. Alongside my experimental training, I developed hands-on skills in computational biology and structural bioinformatics during my PhD and postdoctoral research, using computational approaches to investigate biological systems, protein structure, and drug inhibitors. This early integration of computational and experimental approaches has continued to shape how I approach complex biological and therapeutic questions. I then transitioned from doing science in academia to leading teams in industry, working with biotech and pharmaceutical partners while advancing drug-target programs. As the scale and complexity of my work grew, my role naturally evolved towards scientific operations, program and portfolio management, governance, resource planning, stakeholder alignment, and scientific strategy in a large research enterprise. At present, I intend to logically progress into leading at the convergence of these complementary capabilities in AI × Biology and next-generation drug discovery—leveraging my deep experimental and translational biology foundation, computational biology experience, and ability to connect scientists, programs, and technologies across disciplines.

Career Evolution

Career progression from bench science to AI-enabled biology
$20M–$30M Portfolio Managed
3× Research Enterprise Growth
10–12 Concurrent Scientific Programs
~$1M Investor Approval for Scientific & Business Plan Supporting a novel anti-cancer intervention

Scientific & Strategic Capabilities

Scientific and Strategic Capability Map

Selected Impact

Scientific Operations & Program Infrastructure

Built and implemented program-management and governance infrastructure for a rapidly growing multidisciplinary research center, establishing systems for project planning, resource management, cross-functional coordination, deliverable tracking, hiring, onboarding, and vendor engagement. Led E2E scientific strategy and portfolio evaluation projects supporting biopharma drug discovery.

Translational Drug Discovery & Biopharma Strategy

Hands-on preclinical drug-discovery experience in HIV-1, including small molecules and a novel bi-functional antibody-recruiting inhibitor platform. Delivered scientific consulting and due diligence across oncology, infectious diseases, neurodegeneration, immunology, and rare diseases, spanning diverse therapeutic modalities.

Cross-functional Enterprise Operations

Partnered across IP & Technology Transfer, HR, Finance, Procurement, Regulatory & Compliance, and external vendors/CROs to align scientific programs with organizational and business requirements, enabling complex initiatives to move from strategy through execution.

Scientific Leadership & Team Development

Built and mentored multidisciplinary teams across academic, biotech, and translational research environments, fostering collaboration, trust, accountability, and professional growth. Mentored students, interns, and team members while enabling teams to deliver complex scientific programs.

Leadership Philosophy

“My impact has expanded from generating discoveries myself, to enabling teams, to orchestrating scientific enterprises— and now to exploring how AI can amplify what science makes possible.”

EDUCATION & CREDENTIALS

Postdoctoral Fellowships: Yale University School of Medicine | Drexel College of Medicine

Education: Ph.D. in Cell & Molecular Biology, University of Houston

Certifications: PMI-PMP | MIT Sloan (AI in Pharma & Biotech) | Drug Regulatory Affairs Certificate